BNET Industries

Last Fiscal Year Sales:$847.0K
  • Private
  • US
Dow Jones Description

We are a specialty healthcare company focused on the discovery, development and commercialization of proprietary pharmaceuticals, drug delivery technologies, diagnostic systems, and instruments for the treatment, diagnosis and management of ophthalmic diseases and conditions. Our business presently consists of the development of ophthalmic pharmaceuticals and the development, commercialization and sale of ophthalmic diagnostic and imaging systems and instrumentation products. Our objective is to establish industry-leading positions in large and rapidly growing segments of ophthalmology by leveraging our preclinical and development expertise and our novel and proprietary technologies. We actively explore opportunities to acquire complementary pharmaceuticals, compounds, and technologies, which could, individually or in the aggregate, materially increase the scale of our business. We also intend to explore strategic opportunities in other medical markets that would allow us to benefit from our business and global distribution expertise, and which have operational characteristics that are similar to ophthalmology, such as dermatology. We intend to expand under the following strategic objectives: Leverage R&D strengths to develop our pharmaceutical product pipeline . ...

President, Administration
Steven D. Rubin
Number of Employees 57
Contact Information

4400 Biscayne Blvd Ste 900

Miami, Florida 33137

opko.com

(305) 575-6015

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Opko Health Finalizes Purchase of NK-1 Compounds from Schering

    11/17/09 - Merger / Acquisition - View Story

  • OPKO Health acquires neurokinin-1 receptor antagonist from Schering-Plough

    11/12/09 - Joint Venture / Alliance - View Story

  • Opko Health narrows losses, reduces costs

    11/09/09 - Financial Announcement - View Story

  • OPKO Health acquires Chilean pharmaceutical company Pharma Genexx

    11/05/09 - Merger / Acquisition - View Story

  • Sales Of Swine Flu Vaccine Boost Sanofi

    10/30/09 - Merger / Acquisition - View Story

  • OPKO to Acquire Schering-Plough's Nausea Programme

    10/14/09 - Merger / Acquisition - View Story

  • Opko Health acquires lead neurokinin-1 compounds from Schering-Plough

    10/14/09 - Joint Venture / Alliance - View Story

  • Opko to buy Chilean company for $16M

    10/02/09 - Merger / Acquisition - View Story

  • Opko Health to acquire Pharma Genexx

    10/06/09 - Merger / Acquisition - View Story

  • Molecular Detection Names Todd M. Wallach CEO

    10/01/09 - Merger / Acquisition - View Story

  • Opko to raise $30M in private placement

    9/22/09 - New Investment - View Story

  • Opko narrows losses

    8/10/09 - Financial Announcement - View Story

  • OPKO Acquires Novel Vaccine Technology from Academia Sinica

    7/20/09 - Joint Venture / Alliance - View Story

  • Sorrento Therapeutics Goes Public In Reverse Merger

    7/14/09 - Merger / Acquisition - View Story

  • Frost-led group invests in InterClick

    7/14/09 - New Investment - View Story

  • OPKO Acquires New Platform Technology

    6/17/09 - Board Member - Entering - View Story

  • OPKO Invests in Biotechnology Company with Novel Approach to Developing New Drugs

    6/15/09 - New Investment - View Story

  • Jamie Freedman, M.D., Ph.D. Joins OPKO Health as Executive Vice President of R&D and Business...

    6/17/09 - Mgmt. Change Entering - Business Development - View Story

Decision Makers

Name (plus bio) Position
Steven D. Rubin President, Administration
Adam Logal Executive Director of Finance, Chief Accounting Officer and Treasurer (Principal Accounting Officer)
David F Hostelley Chief Financial Officer
Dr. Jane H. Hsiao PhD Chief Technical Officer
Naveed K Shams Senior Vice President Research and Development and Chief Medical Officer
Rao Uppaluri Chief Financial Officer
Subbarao V. Uppaluri Cfo & Senior Vice President
Samuel J Reich Executive Vice President
Steven Verdooner Executive Vice President, Instrumentation
Coulevard Biscayne
Kate Inman Deputy General Counsel
David Lee Spencer Director
Dr. Richard A. Lerner Director
Robert Baron Director
Robert Benou Director

Board of Directors

Name (plus bio) Position
Alice Lin-Tsing Board of Directors
Alice Lin-Tsing Yu Board of Directors
David Eichler Board of Directors
John A Paganelli Board of Directors
Michael Reich Board of Directors
Pascal J. Goldschmidt Board of Directors
Richard C. Pfenniger Chairman
Thomas E. Beier Board of Directors

Organization Position Status
Opko Health, Inc. President, Administration Current
Opko Health, Inc. Executive Vice President Current
Neovasc Medical Chairman of the Boards of Directors Current
Neovasc Inc. Chairman of The Boards of Directors Current
Opko Health, Inc. Director Current
Ideation Acquisition Corp. Secretary Current
Dreams Inc. Board of Directors Current
Cellular Technical Services Co, Inc. Board of Directors Current
Neovasc Inc. Board of Directors Current
Medical Ventures Corp. Board of Directors Current
The Frost Group Board of Directors Current
Telergy Senior Vice President Former
Telergy General Counsel Former
Stearns Weaver Miller Weissler Alhadeff & Sitterson Former
B-Balloon Ltd. Chairman of the Boards of Directors Former
Telergy Secretary Former
B-Balloon Ltd. Director Former
University of Florida J.D. Degree Former
Tulane University B.A. Former
Neovasc Medical Board of Directors Current

Organization Position Status
Opko Health, Inc. Executive Director of Finance, Chief Accounting Officer and Treasurer (Principal Accounting Officer) Current

David F. Hostelley. Mr. Hostelley has served as our chief financial officer since July 1, 2005. Dr. Hostelley is a Certified Public Accountant licensed in the states of Ohio and New York. In 1984 he earned his Ph.D. in management while a lecturer in the MBA Program of Baldwin-Wallace College. He currently lectures in Accounting and Management for Myers University, Cleveland, Ohio. He has structured numerous acquisitions in the fields of printing, oil and gas development, private schools, insurance agencies, hotels, manufacturing, debit card issuance, health clubs and service entities. In his capacity of trainer in the field of Project Management, Dr. Hostelley has taught the executives of: Ford Motor Company, Westinghouse, National Fuel Gas, General Electric, Stromberg-Carlson, Doehler-Jarvis, Marvin Windows, Progressive Insurance, EDI Engineering, Sun Exploration, Tennessee Valley Authority, SPX Corporation, The Venezuelan Oil Ministry, Ford Museum in Greenfield Village, and Trans Ohio Savings and Loan. He has lectured in South Africa, Venezuela, Canada, and the United States. He is now serving as interim president and board member of Organetix, Inc., (Symbol OGTX.OB); and as a board member and CFO of DSI Direct Sales, Inc. (Symbol DSDI.STET). Mr. Hostelley currently serves on the Executive Committee of the Cleveland Chapter of the Muscular Dystrophy Association.

Organization Position Status
Organetix Interim President Current
Opko Health, Inc. Chief Financial Officer Current
Organetix Board Member Current

Organization Position Status
Opko Health, Inc. Chief Technical Officer Current
Non-Invasive Monitoring Systems Inc. Chairman Current
Modigene Inc. Board of Directors Current
Neovasc Medical Board of Directors Current
Medical Ventures Corp. Board of Directors Current
Opko Health, Inc. Vice Chairman Current
The Frost Group Board of Directors Current
IVX Animal Health, Inc. Chairman, President & Chief Executive Officer Former
DVM Pharmaceuticals, Inc. Chief Executive Officer Former
DVM Pharmaceuticals, Inc. President Former
IVAX Corporation Vice Chairman-Technical Affairs & Chief Technical Officer Former
DVM Pharmaceuticals, Inc. Chairman Former
Opko Health, Inc. Board of Directors Current
University of Illinois Ph.D. Former

Organization Position Status
Opko Health, Inc. Senior Vice President Research and Development and Chief Medical Officer Current
Opko Health, Inc. See Remarks Former

Organization Position Status
Opko Health, Inc. Chief Financial Officer Current
The Frost Group Board of Directors Current
Non-Invasive Monitoring Systems Inc. Board of Directors Current
Ideation Acquisition Corp. Board of Directors Current
Intercontinental Bank Plc Senior Vice President, Senior Financial Officer & Chief Investment Officer Former
Indiana University Ph.D In Finance Former
Indiana University M.B.A. Former
Andhra University M.S. In Engineering Former
Indiana University B.S. Former
Andhra University B.S. Former

Organization Position Status
Opko Health, Inc. Cfo & Senior Vice President Current
Opko Health, Inc. Board of Directors Current

Organization Position Status
Opko Health, Inc. Executive Vice President Current

Organization Position Status
Opko Health, Inc. Executive Vice President, Instrumentation Current

Organization Position Status
Opko Health, Inc. Current

Kate Inman works as in-house corporate counsel for Concord Camera Corporation based in Hollywood. Prior to this position, she was an associate attorney with Holland & Knight in their Corporate and Securities practice area. Ms. Inman is a graduate of University of Florida College of Law where she earned her J.D. degree in 1998 and ranked #1 in her class. She enjoys traveling, diving and snowboarding and resides in Miami.

Organization Position Status
Kristi House, Inc House Corporate Counsel for Concord Camera Corporation Current
Concord Camera Corporation Corporate Counsel Current
Opko Health, Inc. Deputy General Counsel Current
Kristi House, Inc Board of Directors Current
Holland & Knight LLP Associate Attorney Former
University of Florida Levin College of Law J.D. Degree Former

Organization Position Status
Opko Health, Inc. Board of Directors Current

Organization Position Status
National Taiwan University Professor of Pediatrics Current
University of California, San Diego Professor of Pediatrics Current
Opko Health, Inc. Board of Directors Current

Organization Position Status
Next-Stage Development Group Finance Advisor Current
Psilos Advisor on Finance, Strategy and Business Development Current
Mauna Kea Technologies Inc Member of the Board Current
Opko Health, Inc. Board of Directors Current
Spinematrix, Inc. Board Member Current
Qualitymetric Incorporated Board Observer Current
Cohesive Technologies, Inc. Board Observer Current
Lesconcierges, Inc. Director Current
DynCorp International Inc. Defense Policy Analyst Former
Wasserstein Perella Investment Banker Former
Caregiver Services, Inc. Director Former
Georgetown University Masters Degree In National Security Studies Former
Darden Graduate School of Business Administration MBA Former
Cornell University Undergraduate Degree Former

Organization Position Status
Opko Health, Inc. Director Current

Organization Position Status
Sanford Consortium President of the Scripps Research Institute In La Jolla Current
Bay City Capital LLC Advisor Current
The Scripps Research Institute Lita Annenberg Hazen Professor Current
Sequenom, Inc. Professor Current
Bay City Capital LLC Chairman Current
Acrosec Ltd Board of Directors Current
National Academy of Sciences Board of Directors Current
Kraft Foods Inc. Board of Directors Current
Padres L.P. Board Member Current
Sanford Consortium Board of Directors Current
Big Brothers, Inc. Board Member Current
Intra-Cellular Therapies, Inc. Board of Directors Current
Opko Health, Inc. Director Current
Sequenom, Inc. Board of Directors Current
Xencor, Inc. Board of Directors Current
Covx Research LLC President of the Scripps Research Institute In La Jolla Former
Scripps Clinic Former
The Wistar Institute Former
Dyadic International, Inc. Chairman Former
Stanford University School of Medicine M.D. Degrees Former
Stanford University School of Medicine B.S. Former
Northwestern University Former
National Academy of Sciences member Former

Organization Position Status
Rfg & Associates Partner Current
Opko Health, Inc. Board of Directors Current
Opko Health, Inc. Director, Chairman of the Board, Interim Chief Executive Officer, and Secretary Former
Mid Atlantic Medical Services, Inc. Board of Directors Former
Virginia Military Institute A.B. Former

Organization Position Status
Opko Health, Inc. Board of Directors Current

Organization Position Status
Um/Sylvester Senior Vice President for Medical Affairs and Dean of the University of Miami Current
Opko Health, Inc. Board of Directors Current
Pediatrix Medical Group, Inc. Director Current
Duke University Medical Center Chief of the Division of Cardiology Former
University of Miami Senior Vice President Former
Duke University Medical Center Faculty, Dept of Medicine Former
Duke University Medical Center Chairman Former
Department of Medicine Board of Directors Former
The Johns Hopkins University Former

Organization Position Status
Continucare Corporation Chief Executive Officer Current
Continucare Corporation President Current
Opko Health, Inc. Chairman Current
Continucare Corporation Chairman of the Board Current
Cellular Technical Services Co, Inc. Director Current
GP Strategies Corporation Board of Directors Current
General Physics Corporation Board of Directors Current
IVAX Corporation Chief Operating Officer Former
IVAX Corporation Senior Vice President Former
Legal Affairs Senior Vice President Former
IVAX Corporation General Counsel Former
Opko Health, Inc. Director Former

Organization Position Status
Nanosensors, Inc. Chairman & Interim CEO Current
Nanosensors, Inc. Director Former
Hemobiotech, Inc. Director Current
Opko Health, Inc. Director Current
Meyers Associates L.P Partner Former
City, Ltd. Chairman Former
Texas Tech University B.S. In Mechanical Engineering Former
The Ohio State University B.S. Degree Former
The Ohio State University Degree In Business Former

Organization Position Status
Opko Health, Inc. Director Current

Organization Position Status
Ideation Acquisition Corp. Board of Directors Current
Opko Health, Inc. Board of Directors Current
University of Miami B.B.A. In Accounting Former

Executive News

  • Continucare Corporation Reports 52% Increase in Net Income for Fourth Quarter of Fiscal 2009

    DiGiTAL50 - 9/10/09 - View Story

  • Continucare Corporation Reports 52% Increase in Net Income for Fourth Quarter of Fiscal 2009

    Business Wire - 9/10/09 - View Story

  • Continucare Corporation Reports 52% Increase in Net Income for Fourth Quarter of Fiscal 2009

    Stockwatch - 9/10/09 - View Story

  • Continucare acquires sleep centers

    Biz Journals - 8/13/09 - View Story

  • Continucare acquires sleep centers

    South Florida Business Journal - 8/13/09 - View Story

  • Opko narrows losses

    Biz Journals - 8/10/09 - View Story

  • PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

    PR Newswire - 7/24/09 - View Story

  • Six S. Fla. hospitals receive top rankings

    South Florida Business Journal - 7/16/09 - View Story

advertisement
advertisement
Click Here